Status:
COMPLETED
The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
Lead Sponsor:
Gulhane School of Medicine
Conditions:
Diabetes
Proteinuria
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Long pentraxin 3 (PTX3) is a recently discovered multimeric inflammatory mediator structurally linked to CRP and serum amyloid P-component. There is no data about the effects of Renin angiotensin syst...
Detailed Description
The patients who were non-obese (BMI\<30kg/m2), non dyslipidemic (total cholesterol \<200mg/dl, Triglyceride\<150mg/dl), and free of cardiovascular events (negative medical history, negative ECG findi...
Eligibility Criteria
Inclusion
- CKD stage 1 patients
- Older than 18 years of age
- Type 2 Diabetic patients
- Proteinuria
Exclusion
- History of coronary artery disease
- Smokers
- Taking statins or renin-angiotensin blockers
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00674596
Start Date
January 1 2006
End Date
March 1 2008
Last Update
May 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gulhane School of Medicine
Ankara, Turkey (Türkiye), 06018